Recent advances in molecular medicine techniques for the diagnosis, prevention, and control of infectious diseases (Q38075857)

28 August 2017

2 references

3 July 2021

Recent advances in molecular medicine techniques for the diagnosis, prevention, and control of infectious diseases (English)

1 reference

molecular diagnostic techniques

28 August 2017

1 reference

3 July 2021

R F O França

1

1 reference

28 August 2017

C C da Silva

series ordinal

2

1 reference

28 August 2017

S O De Paula

series ordinal

3

1 reference

28 August 2017

22 January 2013

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

28 August 2017

1 June 2013

1 reference

3 July 2021

2 references

28 August 2017

3 July 2021

32

1 reference

28 August 2017

6

1 reference

28 August 2017

723-728

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-013-1813-0

28 August 2017

0 references

cites work

The perpetual challenge of infectious diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

The persistent legacy of the 1918 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Extensively drug-resistant tuberculosis: epidemiology and management challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Emerging infections: a perpetual challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Global spread and persistence of dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Stable introduction of a life-shortening Wolbachia infection into the mosquito Aedes aegypti

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Educating about HIV: prevention, impact mitigation and care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Genotypic characteristics of HIV type 1 based on gp120 hypervariable region 3 of isolates from Southern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Evaluation of a multiplex real time reverse transcription PCR assay for the detection and quantitation of the most common human rotavirus genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Development and evaluation of one step single tube multiplex RT-PCR for rapid detection and typing of dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Human influenza A virus (H5N1) detection by a novel multiplex PCR typing method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Emerging molecular assays for detection and characterization of respiratory viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Analysis of hepatitis C virus intrahost diversity across the coding region by ultradeep pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Advances in the diagnosis of pulmonary tuberculosis in HIV-infected and HIV-uninfected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Magnetoresistive immunosensor for the detection of Escherichia coli O157:H7 including a microfluidic network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Multiplex pathogen identification for polymicrobial urinary tract infections using biosensor technology: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Vaccines: the Fourth Century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Efficacy results of a trial of a herpes simplex vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1813-0

A short history of the polymerase chain reaction.

21 January 2018

1 reference

12 December 2020

Reflections on 30 years of AIDS.

1 reference

12 December 2020

Assembly and characterization of pandemic influenza A H1N1 genome in nasopharyngeal swabs using high-throughput pyrosequencing.

1 reference

12 December 2020

Molecular diagnostics of infectious diseases

1 reference

12 December 2020

10.1007/S10096-013-1813-0

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

0 references

1 reference